Letters to the Editor |

Testosterone's Effects Not Limited to Mood—Reply

Judith G. Rabkin, PhD, MPH; Richard Rabkin, MD; Glenn J. Wagner, PhD
Arch Gen Psychiatry. 2001;58(4):403-404. doi:.
Text Size: A A A
Published online


In reply

We appreciate the thoughtful letter from Dr Daly and his colleagues, and agree with their central point that our study does not provide justification for use of testosterone as a "routine treatment for depression." As we noted at the outset, this study was designed to assess the effects of testosterone on several hypogonadal symptoms reported by men with human immunodeficiency virus/acquired immunodeficiency syndrome, and was not intended as an efficacy trial for the treatment of depression. In fact, since alleviation of syndromal depression was not a primary study goal, we did not stratify for this diagnosis. However, in a previous study we reported improved mood in 34 men with dysthymia or major depression treated openly with testosterone, and no change in mood in those randomized to placebo, in a double-blind discontinuation phase.1 Together, these findings indicate that the antidepressant effects of testosterone warrant further study. Accordingly, we are now conducting a placebo-controlled double-blind trial of fluoxetine and testosterone for depressed men with human immunodeficiency virus infections.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





April 1, 2001
Judith G. Rabkin, PhD, MPH; Richard Rabkin, MD; Glenn J. Wagner, PhD
Arch Gen Psychiatry. 2001;58(4):403-404. doi:.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...